Two Indian Nationals Charged in U.S. Over Alleged Counterfeit Ozempic Smuggling From China
U.S. prosecutors in Florida have charged two Indian nationals in connection with an alleged scheme to smuggle counterfeit Ozempic into the United States from China, according to the Justice Department. The case lands amid surging American demand for GLP-1 drugs used for weight loss, intensifying pressure on regulators and law enforcement to police a fast-growing and lucrative gray market.
